Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis

医学 脂肪肝 荟萃分析 人口 疾病 肥胖 内科学 入射(几何) 科克伦图书馆 环境卫生 光学 物理
作者
Qing Ye,Biyao Zou,Yee Hui Yeo,Jie Li,Daniel Q. Huang,Yuankai Wu,Hongli Yang,Chuanli Liu,Leslie Y. Kam,Xiang Xuan Eunice Tan,Nicholas Chien,Sam Trinh,Linda Henry,Christopher D Stave,Tetsuya Hosaka,Ramsey Cheung,Mindie H. Nguyen
出处
期刊:The Lancet Gastroenterology & Hepatology [Elsevier]
卷期号:5 (8): 739-752 被引量:622
标识
DOI:10.1016/s2468-1253(20)30077-7
摘要

Although non-alcoholic fatty liver disease (NAFLD) is commonly associated with obesity, it is increasingly being identified in non-obese individuals. We aimed to characterise the prevalence, incidence, and long-term outcomes of non-obese or lean NAFLD at a global level.For this systematic review and meta-analysis, we searched PubMed, Embase, Scopus, and the Cochrane Library from inception to May 1, 2019, for relevant original research articles without any language restrictions. The literature search and data extraction were done independently by two investigators. Primary outcomes were the prevalence of non-obese or lean people within the NAFLD group and the prevalence of non-obese or lean NAFLD in the general, non-obese, and lean populations; the incidence of NAFLD among non-obese and lean populations; and long-term outcomes of non-obese people with NAFLD. We also aimed to characterise the demographic, clinical, and histological characteristics of individuals with non-obese NAFLD.We identified 93 studies (n=10 576 383) from 24 countries or areas: 84 studies (n=10 530 308) were used for the prevalence analysis, five (n=9121) were used for the incidence analysis, and eight (n=36 954) were used for the outcomes analysis. Within the NAFLD population, 19·2% (95% CI 15·9-23·0) of people were lean and 40·8% (36·6-45·1) were non-obese. The prevalence of non-obese NAFLD in the general population varied from 25% or lower in some countries (eg, Malaysia and Pakistan) to higher than 50% in others (eg, Austria, Mexico, and Sweden). In the general population (comprising individuals with and without NAFLD), 12·1% (95% CI 9·3-15·6) of people had non-obese NAFLD and 5·1% (3·7-7·0) had lean NAFLD. The incidence of NAFLD in the non-obese population (without NAFLD at baseline) was 24·6 (95% CI 13·4-39·2) per 1000 person-years. Among people with non-obese or lean NALFD, 39·0% (95% CI 24·1-56·3) had non-alcoholic steatohepatitis, 29·2% (21·9-37·9) had significant fibrosis (stage ≥2), and 3·2% (1·5-5·7) had cirrhosis. Among the non-obese or lean NAFLD population, the incidence of all-cause mortality was 12·1 (95% CI 0·5-38·8) per 1000 person-years, that for liver-related mortality was 4·1 (1·9-7·1) per 1000 person-years, cardiovascular-related mortality was 4·0 (0·1-14·9) per 1000 person-years, new-onset diabetes was 12·6 (8·0-18·3) per 1000 person-years, new-onset cardiovascular disease was 18·7 (9·2-31·2) per 1000 person-years, and new-onset hypertension was 56·1 (38·5-77·0) per 1000 person-years. Most analyses were characterised by high heterogeneity.Overall, around 40% of the global NAFLD population was classified as non-obese and almost a fifth was lean. Both non-obese and lean groups had substantial long-term liver and non-liver comorbidities. These findings suggest that obesity should not be the sole criterion for NAFLD screening. Moreover, clinical trials of treatments for NAFLD should include participants across all body-mass index ranges.None.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
PSYxx发布了新的文献求助10
2秒前
pirongshi发布了新的文献求助10
3秒前
summer应助低调点行吗采纳,获得10
3秒前
4秒前
掉渣的饼干完成签到,获得积分10
4秒前
ll完成签到,获得积分20
4秒前
一只五条悟完成签到,获得积分10
4秒前
繁荣的忆文完成签到,获得积分10
4秒前
精明寒蕾完成签到,获得积分10
6秒前
陈陈陈完成签到,获得积分10
6秒前
6秒前
行于繁华完成签到,获得积分10
7秒前
二胡完成签到,获得积分10
7秒前
有人应助加贝采纳,获得10
7秒前
reflux发布了新的文献求助30
8秒前
拓跋子轩完成签到,获得积分10
8秒前
火枪手发布了新的文献求助10
8秒前
善学以致用应助风吹采纳,获得10
8秒前
8秒前
777777777完成签到,获得积分10
8秒前
10秒前
莹亮的星空完成签到,获得积分0
10秒前
spinning完成签到,获得积分10
10秒前
傲娇班完成签到,获得积分10
10秒前
yujia完成签到,获得积分10
10秒前
ale给ale的求助进行了留言
10秒前
万能图书馆应助PSYxx采纳,获得10
11秒前
那兰发布了新的文献求助10
11秒前
滴滴滴完成签到,获得积分20
11秒前
小璐sunny完成签到,获得积分10
12秒前
lgz完成签到,获得积分10
12秒前
sunny完成签到 ,获得积分10
13秒前
高贵姝发布了新的文献求助10
14秒前
asdf完成签到,获得积分10
14秒前
yang完成签到 ,获得积分10
15秒前
中中中中中呀完成签到,获得积分10
15秒前
kaww完成签到,获得积分10
16秒前
Lucas应助wwww采纳,获得10
16秒前
leec发布了新的文献求助20
16秒前
Nobita完成签到,获得积分10
18秒前
高分求助中
The ACS Guide to Scholarly Communication 2500
Sustainability in Tides Chemistry 2000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 810
Pharmacogenomics: Applications to Patient Care, Third Edition 800
Gerard de Lairesse : an artist between stage and studio 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3081744
求助须知:如何正确求助?哪些是违规求助? 2734831
关于积分的说明 7534536
捐赠科研通 2384276
什么是DOI,文献DOI怎么找? 1264252
科研通“疑难数据库(出版商)”最低求助积分说明 612606
版权声明 597600